Debut and Natura to commercialize AI-discovered skin longevity ingredient

Debut, the biotech beauty leader harnessing AI for science, and Natura, the Brazilian multinational and Latin America leader in beauty and personal care, formed a strategic partnership to commercialize an AI-discovered longevity ingredient complex.

The collaboration brings together Debut's proprietary AI for ingredient discovery with Natura's beauty expertise rooted in more than two decades working with the biodiversity of the Amazon Rainforest. Together, the companies will commercialize the AI-discovered complex upon successful clinical validation, uniting Debut's novel actives with Natura's bioactive Amazonian botanicals to deliver best-in-class performance in longevity, a key biological driver of skin aging. Products featuring the longevity complex could be released as soon as 2027.

Debut and Natura partner to create a longevity complex for Latin America, combining AI, biotech and Amazonian bioactives. (Source: Debut, Natura)

"This collaboration represents a new frontier in beauty innovation where advanced science and nature work in synergy to deliver a new standard of clinically validated performance," said Joshua Britton, PhD, Founder and CEO, Debut. "By combining genomics-enabled molecular design with Natura's unique heritage in botanical actives from the Amazon, we are unlocking new possibilities for product innovation."

"At Natura, well-being has always been at our core. Now, we are taking a big step forward: evolving this essence towards functional well-being, backed by science. This collaboration is a key part of our journey into longevity. We are combining three powerful things: nature's billions of years of wisdom, the traditional knowledge of our communities, and the latest in technology and AI. We are using modern science alongside our roots to deliver real, effective results for our customers," said Manuel Rios Krauss, Chief R&D and Innovation Officer, Natura.

For Debut, the partnership marks the company's entry into Latin America alongside the region's leading beauty company. For Natura, the partnership will complement the company's longstanding leadership in nature-based ingredients by gaining access to Debut's proprietary AI platform, which can computationally screen 96 billion molecular possibilities with measurable biological impact and at unprecedented speed. Natura currently utilizes 46 socio-biodiversity bioactives, delivering high-performance functional cosmetics by pairing these natural ingredients with cutting-edge science. Highlights of this portfolio include Ucuuba, known for its intense moisturizing power, and Tukumã, which is naturally rich in hyaluronic acid.

The resulting longevity complex will bridge precision biotechnology and nature and is poised to drive the next wave of Natura's product innovation. What would traditionally require an estimated 125,000 years through conventional screening can be achieved in days using Debut's proprietary platform.